Companies: 10,795·Total market cap: $144.5T
Cynata Therapeutics Limited

Cynata Therapeutics Limited

CYYNFOTCHealthcare● Active
$0.15
$-0.07(-32.58%)
Market Cap$36518100
P/E Ratio
52W High$0.2225
52W Low$0.08

Cynata Therapeutics Limited(CYYNF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CYYNF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$1.89M$2.32M$1.65M$7.77M$1.55M
Cost of Revenue$0.00M$0.28M$0.28M$0.28M$0.28M
Gross Profit$1.89M$2.03M$1.37M$7.49M$1.27M
Gross Margin %(computed)100.00%87.88%83.08%96.40%81.89%
Operating Expenses
R&D Expenses$7.68M$8.96M$12.67M$9.10M$4.06M
G&A Expenses$0.00M$0.00M$3.18M$3.99M$4.22M
Total Operating Expenses$10.01M$11.12M$16.26M$12.06M$7.35M
Operating Income($8.12M)($8.81M)($13.00M)($4.29M)($5.81M)
Operating Margin %(computed)-430.95%-380.37%-785.80%-55.17%-375.61%
Interest Income$0.23M$0.42M$0.35M$0.06M$0.09M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($9.39M)($12.06M)($14.28M)($5.45M)($7.69M)
Income Tax Expense$0.00M($2.32M)$0.00M$0.00M$0.00M
Net Income($9.39M)($9.74M)($14.28M)($5.45M)($7.69M)
Net Margin %(computed)-498.14%-420.82%-863.05%-70.08%-497.38%
Per Share & EBITDA
EPS (Basic)$-0.05$-0.05$-0.10$-0.04$-0.06
Wtd Avg Shares204.95M179.63M145.09M143.28M130.43M
EBITDA($9.33M)($9.95M)($16.26M)($13.56M)($8.80M)
EBITDA Margin %(computed)-494.81%-429.70%-983.04%-174.48%-569.22%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解Cynata Therapeutics Limited

关于Cynata Therapeutics Limited(CYYNF)损益表

Cynata Therapeutics Limited(CYYNF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CYYNF实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.01B)(净利率-498.14%)。

常见问题

CYYNF · 4 问

Cynata Therapeutics Limited(CYYNF)2025财年营收为$0.00B,同比down18.6%。

CYYNF revenueCYYNF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09